Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.

Kawazu M, Kojima S, Ueno T, Totoki Y, Nakamura H, Kunita A, Qu W, Yoshimura J, Soda M, Yasuda T, Hama N, Saito-Adachi M, Sato K, Kohsaka S, Sai E, Ikemura M, Yamamoto S, Ogawa T, Fukayama M, Tada K, Seto Y, Morishita S, Hazama S, Shibata T, Yamashita Y, Mano H.

PLoS Genet. 2017 Jun 21;13(6):e1006853. doi: 10.1371/journal.pgen.1006853. eCollection 2017 Jun.

2.

Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.

Messier TL, Gordon JA, Boyd JR, Tye CE, Browne G, Stein JL, Lian JB, Stein GS.

Oncotarget. 2016 Feb 2;7(5):5094-109. doi: 10.18632/oncotarget.6922.

3.

The role of cytokines in breast cancer development and progression.

Esquivel-Velázquez M, Ostoa-Saloma P, Palacios-Arreola MI, Nava-Castro KE, Castro JI, Morales-Montor J.

J Interferon Cytokine Res. 2015 Jan;35(1):1-16. doi: 10.1089/jir.2014.0026. Epub 2014 Jul 28. Review.

4.

Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations.

Luo Y, Yang C, Ye M, Jin C, Abbruzzese JL, Lee MH, Yeung SC, McKeehan WL.

Cancer Metab. 2013 Nov 25;1(1):21. doi: 10.1186/2049-3002-1-21.

5.

Breast cancer subtyping from plasma proteins.

Zhang F, Chen JY.

BMC Med Genomics. 2013;6 Suppl 1:S6. doi: 10.1186/1755-8794-6-S1-S6. Epub 2013 Jan 23.

6.

Plasma Cytokine Concentrations in Workers Exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Saberi Hosnijeh F, Boers D, Portengen L, Bueno-de-Mesquita HB, Heederik D, Vermeulen R.

Front Oncol. 2012 Apr 11;2:37. doi: 10.3389/fonc.2012.00037. eCollection 2012.

7.

Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.

Furth PA, Nakles RE, Millman S, Diaz-Cruz ES, Cabrera MC.

Breast Cancer Res. 2011 Oct 12;13(5):220. doi: 10.1186/bcr2921. Review.

8.
9.
10.

Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.

Qian L, Lopez V, Seo YA, Kelleher SL.

Am J Physiol Cell Physiol. 2009 Aug;297(2):C369-77. doi: 10.1152/ajpcell.00589.2008. Epub 2009 Jun 3.

11.

Indirect genomic effects on survival from gene expression data.

Ferkingstad E, Frigessi A, Lyng H.

Genome Biol. 2008;9(3):R58. doi: 10.1186/gb-2008-9-3-r58. Epub 2008 Mar 22.

12.

Estrogen receptor-positive mammary tumorigenesis in TGFalpha transgenic mice progresses with progesterone receptor loss.

Rose-Hellekant TA, Schroeder MD, Brockman JL, Zhdankin O, Bolstad R, Chen KS, Gould MN, Schuler LA, Sandgren EP.

Oncogene. 2007 Aug 9;26(36):5238-46. Epub 2007 Mar 5.

13.

Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice.

Arendt LM, Rose-Hellekant TA, Sandgren EP, Schuler LA.

Am J Pathol. 2006 Apr;168(4):1365-74.

Supplemental Content

Support Center